Lactobacillus sakei CVL-001 Enhances MSC Therapy for Ulcerative Colitis
This study explores how pre-conditioning mesenchymal stem cells (MSCs) with Lactobacillus sakei CVL-001 enhances their anti-inflammatory properties in ulcerative colitis. Findings suggest this probiotic-primed approach increases IL-10 secretion, promotes immune balance, and improves disease recovery in colitis models.
